Profil
Dr. Viktor Drvota is a Chairman at KDev Investments AB, a Chairman & Chief Executive Officer at Umecrine Cognition AB, a Chairman at Modus Therapeutics Holding AB, a Chief Executive Officer at Karolinska Development AB (Private Equity), a Chairman at Modus Therapeutics AB and a Deputy Director at SVF Vaccines AB. He is on the Board of Directors at Dilafor AB, Karolinska Development AB (Private Equity), AnaCardio AB, Dilafor Incentive AB, KDev Oncology AB, Organon R&D Finland Oy and Uc Research AB. Dr. Drvota was previously employed as a Deputy Director by Promimic AB, a Chief Executive Officer by KDventures AB, an Independent Director by OssDsign AB, a Board Member by QuickCool AB, a Head-Investment Area Life Science by SEB Venture Capital, an Associate Professor by Karolinska Institutet, a Deputy Director by Avidicare Holding AB, a Chairman by InDex Diagnostics AB, and a Chairman by Scibase Intressenter AB. He also served on the board at Nuevolution AB, Arexis AB, Flerie AB, Airsonett AB, Airsonett Holding AB, Akinion Pharmaceuticals AB, Aprea Therapeutics AB, Avidicare AB, ClanoTech AB, Kanalfläkt Design Alluiq AB, Neoventa Holding AB, Neoventa Medical AB, Nuevolution A/S, OLIGOvation AB, Ovegun AB, Quiatech AB, Sanos Bioscience A/S, SBL Vaccin AB, SciBase AB, SciBase Holding AB and Sjöängensbrygga Ekonomisk Förening.
He received his doctorate degree from Karolinska Institutet.
Aktive Positionen von Viktor Drvota
| Unternehmen | Position | Beginn |
|---|---|---|
| MODUS THERAPEUTICS HOLDING AB | Vorsitzender | 01.01.2016 |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Vorstandsvorsitzender | 01.01.2016 |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Vorstandsvorsitzender | 01.04.2025 |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Vorsitzender | - |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology Engages in research, sales, and development in the fields of medicine and owns and manages investments | Vorsitzender | 01.05.2017 |
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products from heparin derivatives | Direktor/Vorstandsmitglied | 01.03.2016 |
Dilafor Incentive AB | Direktor/Vorstandsmitglied | - |
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Direktor/Vorstandsmitglied | - |
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Direktor/Vorstandsmitglied | - |
| ░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Viktor Drvota
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Viktor Drvota
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 42 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SBL Vaccin AB
SBL Vaccin AB Pharmaceuticals: MajorHealth Technology Develops and produces vaccines | Health Technology |
SEB Venture Capital
SEB Venture Capital Investment ManagersFinance SEB Venture Capital invests in emerging companies located in Sweden. The firm targets companies operating in the fields technology sector, FinTech. It provides financing for early stage capital requirements with an investment size of SEK 10 - 100 million. | Finance |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Finance |
SciBase Holding AB
SciBase Holding AB Medical SpecialtiesHealth Technology Develops point of care device for the detection of malignant melanoma | Health Technology |
Flerie AB
Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
Neoventa Medical AB
Neoventa Medical AB Medical SpecialtiesHealth Technology Provides fetal monitoring solutions and obstetric care services | Health Technology |
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Quiatech AB
Quiatech AB Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Nuevolution AB
Nuevolution AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for treatment of oncology and chronic inflammatory diseases | Health Technology |
OLIGOvation AB
OLIGOvation AB Miscellaneous Commercial ServicesCommercial Services Develops enabling technologies for genetic analysis, molecular diagnostics and gene-based therapeutics | Commercial Services |
Sanos Bioscience A/S
Sanos Bioscience A/S Pharmaceuticals: MajorHealth Technology Develops treatments for osteoporosis and other skeletal wasting diseases | Health Technology |
Airsonett AB
Airsonett AB Medical DistributorsDistribution Services Research and development of a non-pharmaceutical treatment for asthma | Distribution Services |
QuickCool AB
QuickCool AB Medical SpecialtiesHealth Technology Provides non-invasive brain cooling systems | Health Technology |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Health Technology |
Promimic AB
Promimic AB Medical SpecialtiesHealth Technology Develops and markets unique coating for medical implants | Health Technology |
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products from heparin derivatives | Health Technology |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Health Technology |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Health Technology |
ClanoTech AB
ClanoTech AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and macular degeneration | Health Technology |
Karolinska Development AB
Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Neoventa Holding AB
Neoventa Holding AB MiscellaneousMiscellaneous Operates as a holding company for biotechnology research and development | Miscellaneous |
Scibase Intressenter AB | |
InDex Diagnostics AB
InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Commercial Services |
OssDsign AB
OssDsign AB Medical SpecialtiesHealth Technology Designs, manufactures and markets implants for healing and treatment of bone defects | Health Technology |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Health Technology |
Modus Therapeutics Holding AB
Modus Therapeutics Holding AB BiotechnologyHealth Technology Develops sevuparin to treat people suffering from sickle cell disease | Health Technology |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology Engages in research, sales, and development in the fields of medicine and owns and manages investments | Health Technology |
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Health Technology |
Avidicare AB
Avidicare AB Medical DistributorsDistribution Services Provides products that reduces airborne bacteria and virus pollution at hospitals. | Distribution Services |
Scibase AB | |
Nuevolution A/S
Nuevolution A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology | Commercial Services |
Avidicare Holding AB
Avidicare Holding AB Medical SpecialtiesHealth Technology Manufactures of medical devices | Health Technology |
Airsonett Holding AB | |
Svenska Vaccinfabriken Produktion AB
Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines | Health Technology |
Ovegun AB | |
Kanalfläkt Design Alluiq AB
Kanalfläkt Design Alluiq AB Medical SpecialtiesHealth Technology Manufactures medical and dental instruments | Health Technology |
Sjöängensbrygga Ekonomisk Förening | |
Dilafor Incentive AB | |
AnaCardio AB
AnaCardio AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops novel drugs to treat heart failure | Commercial Services |
Uc Research AB |
















